Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Leritrelvir - Guangdong Raynovent Biotech

Next Previous
Drug Profile

Leritrelvir - Guangdong Raynovent Biotech

Alternative Names: RAY-1216

Latest Information Update: 23 Apr 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Guangdong Zhongsheng Pharmaceutical
  • Developer Guangdong Raynovent Biotech; Guangdong Zhongsheng Pharmaceutical
  • Class Antivirals; Small molecules
  • Mechanism of Action Coronavirus 3C-like proteinase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Registered COVID 2019 infections

Most Recent Events

  • 31 Dec 2023 Guangdong Raynovent Biotech completes phase I drug-drug interaction trial in healthy subjects in China (PO) (NCT06031454)
  • 12 Dec 2023 Guangdong Raynovent Biotech completes a phase-I pharmacokinetics trial in China (PO) (NCT06160622)
  • 15 Nov 2023 Guangdong Raynovent Biotech completes a phase I pharmacokinetics trial in Healthy volunteers in China (PO, Suspension) (NCT06362460)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top